HCRP1 expression is decreased in breast cancer tissues and cell lines.
HCRP1 depletion contributes to breast cancer migration and invasion.
HCRP1 depletion decreases EGFR degradation and enhances EGFR phosphorylation in breast cancer.
HCRP1 depletion contributes to insensitivity of anti-EGFR targeted therapy in breast cancer.